Article Information
History
- February 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- K.J. Linde1,*,
- I.M. Wouters1,
- J.A.J.W. Kluytmans5,
- M.F.Q. Kluytmans-van den Bergh5,6,
- S.D. Pas3,
- C.H. GeurtsvanKessel2,
- M.P.G. Koopmans6,
- M. Meier4,
- P. Meijer1,
- C.R. Raben1,
- J. Spithoven1,
- M.H.G. Tersteeg-Zijderveld1,
- D.J.J. Heederik1,
- W. Dohmen1,
- COCON consortium
- 1Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
- 2Department of ViroScience, Erasmus MC, Rotterdam, the Netherlands
- 3Microvida location Amphia/Bravis, Breda/Roosendaal, the Netherlands
- 4Mijzo, Waalwijk, the Netherlands
- 5Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 6Department of Infection Control, Amphia Hospital, Breda, the Netherlands
- ↵*Corresponding author: K J Linde e-mail: K.j.linde{at}uu.nl, Institute for Risk Assessment Sciences, Division Environmental Epidemiology, PO Box 80178, 3508TD Utrecht, The Netherlands